Professor Klaus G Parhofer
Ludwig Maximilians University, Munich (Germany)
Panel discussion and Q&A
Event: ESC Congress 2024
Topic: Lipid-Lowering Agents
Session: Cholesterol lowering in high cardiovascular risk patients with comorbidities: closing gaps and future opportunities
Unmet needs: real-world evidence reveals treatment gaps in patients with diabetes and obesity
Event: ESC Congress 2024
Topic: Lipid-Lowering Agents
Session: Cholesterol lowering in high cardiovascular risk patients with comorbidities: closing gaps and future opportunities
Clinical experience with add-on oral therapy: patient cases..
Event: ESC Congress 2022
Topic: Drug therapy
Session: Optimising the lipid management of high and very high cardiovascular risk patients
Estimating prevalence and characteristics of statin intolerance among high and very high cardiovascular risk patients in Germany between 2017-2020
Event: ESC Congress 2022
Topic: Hospital Information Systems, Electronic Medical Records, Clinical Decision Support
Session: Digital health innovation: from artificial intelligence to clinical decision support
When and how to treat hypertriglyceridemia.
Event: ESC Congress 2021 - The Digital Experience
Topic: Pharmacology and Pharmacotherapy
Session: Lipid lowering beyond LDL-cholesterol and statins
PEARL, a non-interventional study on real-world use of alirocumab in German clinical practice: final study and cardiovascular subgroup data
Event: ESC Congress 2018
Topic: Drug therapy
Session: Preventive cardiology / Lipids
The ODYSSEY ESCAPE study: rationale, design, patient characteristics at baseline, and final study data
Event: ESC Congress 2016
Topic: Lipids
Session: Lipids and coronary artery disease
